The ratio of adiponectin to homeostasis model assessment of insulin resistance is a powerful index of each component of metabolic syndrome in an aged Japanese population: results from the KING Study

Masahiro Nakatochi; Seiko Miyata; Daisuke Tanimura; Hideo Izawa; Hiroyuki Asano; Yosuke Murase; Ryuji Kato; Sahoko Ichihara; Keiko Naruse; Tatsuaki Matsubara; Hiroyuki Honda; Mitsuhiro Yokota

doi:10.1016/j.diabres.2011.02.029

The ratio of adiponectin to homeostasis model assessment of insulin resistance is a powerful index of each component of metabolic syndrome in an aged Japanese population: results from the KING Study

Diabetes Res Clin Pract. 2011 Jun;92(3):e61-5. doi: 10.1016/j.diabres.2011.02.029. Epub 2011 Mar 31.

Authors

Masahiro Nakatochi¹, Seiko Miyata, Daisuke Tanimura, Hideo Izawa, Hiroyuki Asano, Yosuke Murase, Ryuji Kato, Sahoko Ichihara, Keiko Naruse, Tatsuaki Matsubara, Hiroyuki Honda, Mitsuhiro Yokota

Affiliation

¹ Department of Biotechnology, Nagoya University School of Engineering, Nagoya, Japan.

PMID: 21458098
DOI: 10.1016/j.diabres.2011.02.029

Abstract

We evaluated the ratio of adiponectin level to homeostasis model assessment of insulin resistance (A/H ratio) as a risk marker for metabolic syndrome (MetS) and each of its components. The A/H ratio may prove to be a powerful index for evaluation of risk for MetS and each of its components.

Trial registration: ClinicalTrials.gov NCT00262691.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adiponectin / blood*
Aged
Female
Homeostasis / physiology
Humans
Insulin Resistance / physiology*
Male
Metabolic Syndrome / blood*
Middle Aged
Sex Factors

Substances

Adiponectin

Associated data

ClinicalTrials.gov/NCT00262691